Mitch C. Hill - 18 Feb 2023 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Financial Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol: N/A
Transactions as of: 18 Feb 2023
Net transactions value: +$929,544
Form type: 4
Filing time: 22 Feb 2023, 15:51:44 UTC
Previous filing: 15 Feb 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Award	$0	+21,412	+46%	$0.000000	67,892	18 Feb 2023	Direct	F1
holding	NARI	Common Stock						1,600	18 Feb 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to Buy)	Award	$929,544	+16,599		$56.00	16,599	18 Feb 2023	Common Stock	16,599	$56.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	2023 Annual Restricted Stock Units grant ("RSUs"). Vesting Commencement Date begins January 1, 2023, 1/16th of the RSUs shall vest on each quarterly anniversary of the vesting Commencement Date.
F2	These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023.